Elicio Therapeutics News and Activities

Elicio Therapeutics is a company listed under the stock ticker ELTX (US).

View the org chart displaying its 26 main executives

Most searched biographies at Elicio Therapeutics

• Robert Connelly, Chief Executive Officer
• Yekaterina Chudnovsky, Director
• Carol Ashe, Director

Popular executive movements at Elicio Therapeutics

• Marc Wolfgang has joined the company as Chief Technology Officer  (posted on November 20 2025).

Create your alert
to follow the executive moves at Elicio Therapeutics.

Elicio Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Elicio Therapeutics

• Therapeutic Vaccine Could Fight Pancreatic Cancer
• Vaccine ‘may be able to delay relapse in specific pancreatic and bowel cancers’
• Vaccine shows promise as treatment for colorectal, pancreatic cancer
• Elicio initiates Phase II pancreatic cancer vaccine trial
• News | Stay Up to Date With Elicio Therapeutics
• Vaccine Boosts CAR T Cell Therapy for Solid Tumors
• View more press releases Close

Social media about Elicio Therapeutics

• Elicio Therapeutics on Wikipedia, Google News & Yahoo Finance
• Elicio Therapeutics on LinkedIn, X (Twitter) & YouTube